EN
Wszystkie kategorie
EN

Wielofunkcyjna seria monitorowania

Safe AQ UG

Bi-functional blood glucose and uric acid monitoring system; Automatic strips ejection; ISO15197 2013 approved; Smart code for uric acid test

Ogółem

The Safe AQ UG Blood Glucose and Uric Acid Monitoring System is designed for the quantitative measurement of glucose and uric acid in fresh capillary whole blood samples and in venous whole blood samples. The Safe AQ UG Blood Glucose and Uric Acid Monitoring System is for use outside the body only (in vitro diagnostic use) for self-testing and professional use as an aid in the management of diabetes and hyperuricemia (HUA).

Specyfikacja
Funkcja testowa Glukoza we krwi Uric Acid
Metoda badania FAD-GDH Oxidized Ferrocene Derivative
Typ próbki Peripheral capillary whole blood/venous whole blood Peripheral capillary whole blood/venous whole blood
Próbka krwi
0.6µl 3µl
Zakres testowy 20-600mg/dL
(1.1-33.3mmol/L)
3.0-20.0mg/dL
(181-1188 µmol/L)
Czas na test 5s 25s
Pamięć 500 ustawia 100 ustawia
Strip validity Miesiąc 24 Miesiąc 17
◆ Blood glucose user performance evaluation:
Results for glucose concentrations<100 mg/dL (<5.55mmol/l)
W zakresie ± 5mg / dL
(within ± 0.28mmol/l)
W zakresie ± 10mg / dL
(within ± 0.56mmol/l)
W zakresie ± 15mg / dL
(within ± 0.83mmol/l)
50% (14 / 28) 85.71% (24/28) 100% (28/28)
Results for glucose concentrations ≥ 100 mg/dL (≥5.55mmol/l)
W granicach ± ​​5%
W granicach ± ​​10%
W granicach ± ​​15%
55.56% (40 / 72) 90.28% (65 / 72) 97.22% (70 / 72)
◆ Uric acid user performance evaluation:
Results for uric acid concentrations < 297μmol/L (5.0 mg/ dL)
Within ± 14.9μmol/L
(Within ± 0.3 mg/ dL)
Within ± 29.7μmol/L
(Within ± 0.5 mg/ dL)
Within ± 59.4μmol/L
(Within ± 1.0 mg/ dL)
40.0% (6 / 15) 60.0% (9/15) 100% (15/15)
Results for uric acid concentrations≥ 297μmol/L (5.0 mg/ dL)
W granicach ± ​​5%
57.6% (49 / 85)
W granicach ± ​​10%
94.1% (80 / 85)
W granicach ± ​​15%
100% (85 / 85)